Nanowire Device to Detect Circulating Tumor Cells
CSEF · 2013 Biochemistry/ Molecular Biology
Overview
Objectives/Goals In the US, there are over 12 million people that live with cancer, but in about 90% of these cases, most patients die from the metastasis of the primary tumor. Detecting a metastasized tumor at an early stage still remains a challenge because of the limitations in current diagnostic techniques. In order to improve early detection for metastasis, a nanowire device was developed that could efficiently capture and release circulating tumor cells. Methods/Materials The device was fabricated from a unique nanowire silicon substrate and polydimethylsiloxane (PDMS). Biotinylated polymer brushes coated with anti-EpCAM were grafted onto the silicon nanowire substrate to capture circulating tumor cells (CTCs). Cells from prostate and breast cancer cell lines were suspended and were run through the device for each test. Results Using a coating of 10% biotin, the device had a capture efficiency of 70-90% and a high release rate. The nanowire device maintained a high viability of the cells and was able to accurately differentiate between different types of cancerous cells. For released cells, the viability rate was 90%, and CTCs were still viable to undergo additional culturing. The device#s sensitivity was confirmed by its ability to successfully differentiate between EpCAM positive cell lines and EpCAM negative cell lines. The durability of the device was proven by its ability to be used multiple times. Conclusions/Discussion This nanowire device demonstrated the ability to capture and release CTCs at a high rate, accurately differentiate between different cell types, maintain its ability to capture and release the cells after multiple uses, and maintain the viability of the released cells. Not only can this device improve early detection for metastasis, but it can also provide a less invasive option for cancer diagnostics because capturing CTCs only requires a blood draw. With efficient CTC detection and less invasive methods, the nanowire device can lead to significant advancements in cancer diagnosis.
Summary statement
A nanowire device that can efficiently capture and release circulating tumor cells was developed to improve the early detection of cancer.
Help received
Mother provided transportation; used lab equipment at University of California Los Angeles
Competition history
- CSEF 2013
Resources
Related projects
ISEF · 2018
Nanoparticle-Mediated Sorting of Circulating Tumor Cells
ISEF · 2018
Novel Nanotechnology for the Detection of Circulating Tumor Cells
ISEF · 2025
A Novel Spintronics-based Circulating Tumor Cell Biosensor for Early Metastasis Detection
ISEF · 2014
Early Cancer Diagnosis and Treatment through the Detection of Circulating Tumor Cells Using Drop-based Microfluidics
ISEF · 2015
Novel Method of Circulating Prostate Tumor Cell Separation Using Adhesion Rolling in a Micropatterned, Microfluidic Device
ISEF · 2026
A Dual-Field Inertial–Acoustic Microfluidic Chip for Label-Free Circulating Tumor Cell (CTC) Isolation
CSEF · 2006
Micropathology Lab Device for Detecting Molecular Lesions of Glioblastoma
ISEF · 2014
Reduction of Circulating Tumor Cells by Induction of Apoptosis via a TRAIL-Functionalized, Nanostructured Shunt Device
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects